Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| Operating costs | 0.17 | 0.16 | 0.32 | 0.46 | 0.13 | 0.17 | 0.62 | 0.18 | 0.13 | 0.10 | 0.33 | 0.12 |
| EBITDA | -0.12 | -0.11 | -0.27 | -0.41 | -0.07 | -0.09 | -0.54 | -0.13 | -0.08 | -0.05 | -0.28 | -0.06 |
| EBITDA margin % | -240.00% | -220.00% | -540.00% | -820.00% | -116.67% | -112.50% | -675.00% | -260.00% | -160.00% | -100.00% | -560.00% | -100.00% |
| Depreciation & amortisation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Finance costs | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.19 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 |
| Non-operating income | 0.04 | 0.04 | 0.05 | 0.65 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
| Pre-tax profit | -0.13 | -0.12 | -0.27 | 0.20 | -0.07 | -0.09 | -0.71 | -0.43 | -0.39 | -0.37 | -0.46 | -0.39 |
| Effective tax rate % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Profit after tax | -0.13 | -0.12 | -0.27 | 0.20 | -0.07 | -0.09 | -0.71 | -0.43 | -0.39 | -0.37 | -0.46 | -0.39 |
| Earnings per share (Rs) | -0.02 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | -0.09 | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.18 | 0.28 | 0.12 | 0.07 | 0.00 | 0.17 | 0.09 | 0.06 | 0.23 | 0.26 | 0.21 | 0.21 |
| Operating costs | 1.32 | 2.84 | 2.22 | 0.75 | 0.87 | 0.70 | 0.55 | 0.68 | 0.83 | 1.38 | 0.75 | 0.68 |
| EBITDA | -1.14 | -2.56 | -2.10 | -0.68 | -0.87 | -0.53 | -0.46 | -0.62 | -0.60 | -1.12 | -0.54 | -0.47 |
| EBITDA margin % | -633.33% | -914.29% | -1,750.00% | -971.43% | -311.76% | -511.11% | -1,033.33% | -260.87% | -430.77% | -257.14% | -223.81% | |
| Depreciation & amortisation | 20.50 | 17.53 | 9.89 | 9.89 | 9.90 | 9.91 | 9.92 | 4.95 | 0.09 | 0.09 | 0.20 | 0.19 |
| Finance costs | 0.07 | 0.43 | 1.03 | 0.26 | 0.38 | 0.27 | 0.23 | 0.62 | 0.14 | 0.24 | 1.06 | 1.10 |
| Non-operating income | 0.17 | 0.66 | 7.37 | 2.04 | 0.18 | 0.27 | 0.21 | 0.18 | 0.18 | 0.78 | 0.15 | 0.15 |
| Pre-tax profit | -21.54 | -19.86 | -5.65 | -8.79 | -10.97 | -10.44 | -10.40 | -6.01 | -0.65 | -0.67 | -1.65 | -1.61 |
| Effective tax rate % | 0.00% | 0.00% | 13.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Profit after tax | -21.54 | -19.86 | -6.44 | -8.79 | -10.96 | -10.43 | -10.40 | -6.01 | -0.66 | -0.68 | -1.65 | -1.61 |
| Earnings per share (Rs) | -2.84 | -2.62 | -0.85 | -1.16 | -1.45 | -1.38 | -1.37 | -0.79 | -0.09 | -0.09 | -0.22 | -0.21 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | 2% | 4% | 52% | -22% | ||
| Profit CAGR | 7% | 13% | 20% | -24% | ||
| Share price CAGR | 2% | -5% | -13% | -33% | ||
| Average return on equity | -23% | -30% | -10% | -18% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 163.40 | 140.95 | 61.16 | 50.97 | 41.10 | 31.20 | 21.32 | 11.40 | 6.45 | 6.36 | 7.96 | 9.63 |
| Capital work in progress | 0.29 | 0.29 | 2.04 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 |
| Current & other assets | 180.08 | 171.75 | 134.86 | 133.71 | 133.58 | 133.68 | 133.69 | 133.73 | 133.93 | 134.00 | 134.16 | 133.94 |
| Total assets | 343.77 | 312.99 | 198.06 | 186.55 | 176.55 | 166.75 | 156.88 | 147.10 | 142.35 | 142.33 | 144.09 | 143.66 |
| Share capital | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 |
| Reserves & surplus | 115.62 | 98.67 | -16.90 | -23.34 | -32.13 | -43.10 | -53.53 | -58.39 | -64.40 | -65.06 | -65.74 | -67.39 |
| Total debt | 14.43 | 15.28 | 16.01 | 9.84 | 9.14 | 10.33 | 11.33 | 12.01 | 13.11 | 14.00 | 14.52 | 17.14 |
| Other liabilities & provisions | 137.95 | 123.27 | 123.18 | 124.28 | 123.77 | 123.75 | 123.31 | 117.71 | 117.87 | 117.62 | 119.54 | 118.14 |
| Equity + liabilities | 343.77 | 312.99 | 198.06 | 186.55 | 176.55 | 166.75 | 156.88 | 147.10 | 142.35 | 142.33 | 144.09 | 143.66 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.52 | 6.47 | 0.02 | -0.63 | -1.74 | 0.14 | 0.01 | 0.10 | 0.00 | 0.00 | 1.20 | -0.01 |
| Investing cash flow | -4.57 | -6.47 | 0.00 | 3.05 | 1.74 | 0.00 | -0.03 | -0.10 | -0.01 | 0.00 | -1.70 | 0.15 |
| Free cash flow (after capex) | -1.05 | 0.00 | 0.02 | 2.74 | -0.01 | 0.14 | -0.02 | 0.10 | 0.00 | 0.00 | -0.50 | 0.14 |
| Financing cash flow | 1.03 | 0.00 | 0.00 | -2.37 | 0.00 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.78 | -0.36 |
| Net change in cash | -0.02 | 0.00 | 0.02 | 0.05 | 0.00 | -0.06 | -0.01 | 0.00 | -0.01 | 0.00 | 0.28 | -0.22 |
| Cash conversion (OCF / EBITDA) % | -220% | -568% | -1% | 30% | 256% | -16% | -2% | -22% | 0% | 0% | -107% | 2% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on capital employed % | -8.83% | -10.86% | -14.69% | -10.97% | -17.91% | -22.11% | -26.56% | -32.31% | -20.01% | -2.07% | -1.75% | -2.36% |
| Receivable days | 19,953.33 | 3,325.56 | 13.04 | 30.42 | 52.14 | 21.47 | 40.56 | 60.83 | 15.87 | 14.04 | 17.38 | |
| Inventory days | 365.00 | 365.00 | 1,460.00 | 121.67 | 156.43 | |||||||
| Payable days | 5,018.75 | 3,528.33 | 13,870.00 | 1,460.00 | 1,199.29 | |||||||
| Cash cycle (days) | 19,953.33 | 3,325.56 | 13.04 | -4,623.33 | -3,111.19 | -1,316.86 | 40.56 | -982.02 | 15.87 | 14.04 | 17.38 | |
| Working capital days | -8,528.83 | -16,019.44 | -14,339.29 | -39,967.50 | -62,519.29 | -29,092.65 | -34,593.89 | -57,365.83 | -15,933.04 | -16,509.23 | -21,361.19 |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% |
| Retail & others % | 76.37% | 76.36% | 76.36% | 76.36% | 76.37% | 76.37% | 76.38% | 76.37% | 76.37% | 76.37% | 76.37% | 76.37% |
| Shareholder count | 11,360 | 12,220 | 12,426 | 12,766 | 12,963 | 13,307 | 13,583 | 13,475 | 13,461 | 13,545 | 13,767 | 13,817 |
Fundamentals
Market value₹ 19.9 Cr.
Last price₹ 2.62
Book value / share₹ 1.11
Return on capital-2.36 %
Return on equity-17.9 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-22%
Profit CAGR (TTM)-24%
Consolidated figures.
Valuation
Market capRs 18 Cr
Enterprise valueRs 35 Cr
Price to book2.17x
Price to sales86.63x
EV / sales167.96x
Earnings yield-8.85%
P/B, 3-year average4.14x
P/B, 5-year average2.88x
Profitability
Operating margin (excl. other income)-257.14%
Operating margin (incl. other income)-185.71%
EBITDA margin-152.38%
Pre-tax margin-766.67%
Net profit margin-766.67%
Net margin, latest quarter-650.00%
ROE-17.93%
ROCE-2.36%
ROA-1.15%
ROE, 3-year average-10.15%
ROCE, 3-year average-2.06%
ROA, 3-year average-0.70%
ROE, 5-year average-24.95%
ROCE, 5-year average-11.70%
ROA, 5-year average-2.62%
ROIC (approx.)-2.00%
Other income / net worth1.79%
Growth
Sales growth (latest year)-19.23%
Sales CAGR, 3 years51.83%
Sales CAGR, 5 years4.32%
Sales growth QoQ20.00%
Sales growth YoY (latest quarter)20.00%
Per share
EPS (TTM)Rs -0.21
EPS (latest quarter)Rs -0.05
EPS, 3-year averageRs -0.09
EPS, 5-year averageRs -0.59
Book value per shareRs 1.11
Sales per shareRs 0.03
Cash flow per shareRs -0.00
Efficiency
Asset turnover0.00x
Fixed asset turnover0.02x
Inventory turnover0.00x
Debtor days17 days
Debtors turnover21.00x
Leverage
Total debtRs 17 Cr
Cash and bankRs 0 Cr
Net debtRs 17 Cr
Debt to equity2.05x
Interest coverage-0.46x
Owners' fund to total sources5.83%
Debt to assets11.93%
Cash flow
Operating cash flow (latest year)Rs -0 Cr
Investing cash flow (latest year)Rs 0 Cr
Financing cash flow (latest year)Rs -0 Cr
Net change in cash (latest year)Rs -0 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -1 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -2 Cr
Net profit (TTM)Rs -2 Cr
Net profit (latest year)Rs -2 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 1 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 76 Cr
ReservesRs -67 Cr
Shareholders' fundsRs 8 Cr
Total assetsRs 144 Cr
Net blockRs 10 Cr
InvestmentsRs 0 Cr
ReceivablesRs 0 Cr
InventoryRs 0 Cr
Other liabilitiesRs 118 Cr
Shares outstanding (crore)7.58
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 2.17 is at the 67th percentile (median 1.26).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 526139 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -8.0% | -2.8% | -5.3 pts |
| 1 month | -16.7% | -6.8% | -9.9 pts |
| 3 months | -20.8% | -7.6% | -13.2 pts |
| 3 years | -41.3% | +14.2% | -55.5 pts |
| 5 years | -32.4% | +27.9% | -60.3 pts |
Red flags
F-score 3 of 8| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr +20.0% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Transgene Biotek Ltd?
Transgene Biotek Ltd (526139) has a market capitalisation of Rs 19.9 Cr. at the 2026-10-01 close.
What were Transgene Biotek Ltd's latest quarterly results?
In the Jun 2026 quarter, Transgene Biotek Ltd sales was Rs 0 Cr (+20.0% vs Jun 2025) with a net loss of Rs 0 Cr.